Free Trial

Sensei Biotherapeutics (SNSE) SEC Filings & 10K Form

$0.74
-0.02 (-2.63%)
(As of 05/31/2024 ET)

Recent Sensei Biotherapeutics SEC Filings

DateFilerForm TypeView
05/23/2024
4:10 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:37 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:35 PM
Sensei Biotherapeutics (Filer)
Form DEFA14A
04/29/2024
3:40 PM
Sensei Biotherapeutics (Filer)
Form ARS
04/12/2024
3:31 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
6:45 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
5:00 PM
Newtyn Management, LLC (Filed by)
Sensei Biotherapeutics (Subject)
Form SC 13D/A
02/29/2024
3:44 PM
Sensei Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
6:31 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
5:25 PM
Colgan Erin (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:28 PM
Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:37 PM
Sensei Biotherapeutics (Issuer)
van der Horst Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:34 PM
Newtyn Management, LLC (Filed by)
Sensei Biotherapeutics (Subject)
Form SC 13D/A
01/04/2024
7:14 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:40 PM
Sensei Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
6:35 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
5:07 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:50 PM
Krebs Stephanie (Reporting)
Sensei Biotherapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/02/2023
3:53 PM
Krebs Stephanie (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2023
4:01 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
7:43 AM
Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:31 PM
Colgan Erin (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:33 PM
Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:33 PM
Sensei Biotherapeutics (Issuer)
van der Horst Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:34 PM
Gallagher Patrick Stephen (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
4:15 PM
Sensei Biotherapeutics (Filer)
Form 424B5
08/04/2023
3:41 PM
Cambrian BioPharma Inc (Filed by)
Sensei Biotherapeutics (Subject)
Form SC 13G/A
08/03/2023
3:32 PM
Sensei Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
7:45 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
4:00 PM
Broder Samuel (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
4:02 PM
RICKS THOMAS G (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
4:03 PM
RINGO WILLIAM R (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:44 PM
Holmen Bob (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:46 PM
Sensei Biotherapeutics (Issuer)
Vojta Deneen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:48 PM
English Jessie (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:50 PM
Humer Kristian (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
3:31 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
8:00 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
3:30 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
3:41 PM
Sensei Biotherapeutics (Filer)
Form ARS
06/15/2023
3:31 PM
Sensei Biotherapeutics (Filer)
Form DEF 14A
This military-backed stock “owns” AI market (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SNSE) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners